Improving HIV Treatment Adherence Through Long-Acting Injectables: A Comparative Study of Cabenuva and Oral ART at a Ryan White-Funded Clinic
This study highlights Cabenuva’s potential to reduce adherence gaps and improve outcomes in structurally marginalized populations. The findings support further implementation of long-acting regimens and may inform policies aimed at increasing treatment access and equity in HIV care.